Patients with chronic liver disease had an increased risk for poor COVID-19 outcomes, and liver-specific risk factors include al ...MORE
A randomized trial, published in JAMA Oncology, has revealed that laparoscopic surgery, performed by an experienced sur ...MORE
Individuals with recent-onset diabetes associated with weight loss appeared to have an increased risk for pancreatic cancer and ...MORE
The FDA has granted approval to single-agent nivolumab as a second-line treatment for advanced esophageal squamous cell carcinom ...MORE
The FDA has granted approval to the PD-L1 immune checkpoint inhibitor atezolizumab for the first-line treatment of unresectable ...MORE
The U.S. Food and Drug Administration has granted approval to ripretinib as the first new drug approved as a fourth-line treatme ...MORE
| Prev123Next |
